Related Experiment Video
Updated: May 22, 2026

A Preclinical Model of Sepsis-Induced Myopathy with Disuse in Mice
Published on: June 14, 2024
Rhabdomyolysis and severe muscle weakness secondary to colistin therapy
Gülsüm Özkan1, Şükrü Ulusoy, Sibel Gazioğlu
1Department of Nephrology, School of Medicine, Karadeniz Technical University, Trabzon, Turkey. gulsumozkan78@hotmail.com
Abstract:
Rhabdomyolysis is a clinical condition that causes renal failure up to 40%. Rhabdomyolysis may be traumatic or nontraumatic. Colistin (polymyxin E) is an effective antibiotic. Nephrotoxicity is a frequently encountered side effect. The nephrotoxic effect of colistin is thought to be associated with increased membrane permeability, cell swelling and lysis, and the development of acute tubular necrosis. Here, we report a case of nontraumatic rhabdomyolysis associated with the use of colistin. There is only one report of rhabdomyolysis secondary to colistin in the literature, and there is no report of a case developing severe tetraparesis, as in our case.
Related Concept Videos
Skeletal Muscle Relaxants: Adverse Effects
Unlike...
Nephrotic Syndrome I : Introduction
Overview of Protein Metabolism
Amino acids play various roles in the body once they are absorbed into cells. They are restructured...
Inhibitors of Bacterial Protein Synthesis
Chronic Kidney Disease II: Clinical Manifestations
Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications
